Home ANTEROGEN

ANTEROGEN

In operation
IPO
Rare Disease Drug Research, Development, and Manufacturing
Basic
Enterprise Profile

Basic Information

The company develops therapeutic agents for rare and refractory diseases to achieve human health and happiness. Based on respect for humanity, the company creates a healthy corporate culture and grows into an enterprise that fulfills social responsibilities.
ANTEROGEN.CO.,LTD.
--
15~50 people
January 01, 2000
--

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production
Technology
Stem Cell Technology
Concept
Rare Diseases
Application Scenarios
Innovative Drugs Cell and Gene Therapy